Insider Transactions Reported by 25 Insiders of Zymeworks Inc.

Symbol
ZYME on Nasdaq
Location
Middletown, DE

Insiders trading volume in the past year

Zymeworks Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
EcoR1 Capital, LLC Director, 10%+ Owner $342M +$40.3M +13.4% 26 Jun 2025
OLEG NODELMAN Director, 10%+ Owner $218M 17 Feb 2025
Redmile Group, LLC 10%+ Owner $30.6M 13 Oct 2022
Kenneth Galbraith Chair & CEO, Director $6.47M -$2.14M -24.9% 22 Dec 2025
Gregory Austin Ciongoli Director $5.94M 11 Aug 2025
Paul Andrew Moore Chief Scientific Officer $1.14M -$316K -21.7% 10 Jan 2025
Jeffrey T L Smith EVP & Chief Medical Officer $924K -$166K -15.2% 10 Jan 2025
LEONE D. PATTERSON EVP, Chief Bus & Fin Officer $791K 10 Jan 2025
Christopher Astle SVP & Chief Financial Officer $409K 05 Jan 2024
Neil Josephson Chief Medical Officer $294K 10 Nov 2022
Neil Klompas President & COO $229K 10 Mar 2023
Nancy Davidson Director 10 Dec 2024
Kelvin Neu Director 10 Dec 2024
Robert E. Landry Director 11 Aug 2025
Carlos Campoy Director 10 Dec 2024
Alessandra Cesano Director 10 Dec 2024
Scott Platshon Director 22 Feb 2024
Kenneth J. Hillan Director 07 Dec 2023
Lota S. Zoth Director 21 Dec 2022
Susan Mahony Director 10 Dec 2024
Neil Gallagher Director 10 Dec 2024
Derek John Michael Miller Director 10 Dec 2024
Natalie Sacks Director 21 Dec 2022
Troy Cox Director 10 Dec 2024
HOLLINGS RENTON Director 07 Dec 2023

Recent Insider Transactions by Companies or Individuals for Zymeworks Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.